Clinical Trials Logo

Clinical Trial Summary

The main purpose of the study is to confirm the clinical performance and safety of impedance spectroscopy using the ONIRY device for the detection of anal sphincter injuries arising from vaginal deliveries. The study group comprises 150 primiparous or multiparous women up to 8 weeks after the vaginal (spontaneous or assisted) delivery of singleton, live foetus, in any presentation, in gestational week 34 or more. The timeline for each subject in the study will be up to 5 weeks and will include 3 visits (V1-V3). All participants will be divided into 3 groups: A, B, C. Group A - subjects with no perineal tear signs, Group B - subjects with grade 1 or 2 per OASIS classification, and Group C - subjects with grade 3 or 4). The diagnostic performance will be evaluated in comparison to 3-D EUS (endoanal ultrasound) as a primary performance measure (primary endpoint).


Clinical Trial Description

The main purpose of the study is to confirm the clinical performance and safety of impedance spectroscopy using the ONIRY device for the detection of anal sphincter injuries arising from vaginal deliveries. The whole study is divided into 2 parts. Part I is a clinical trial; after completion of Part I, an analytical classification model will be established (during Part II) based on data from pilot studies and Part I of the study. It will be then built into the ONIRY Meter as a machine-learning-based interpretation module; proposed for ultimate marketing authorisation. Part I of the study will be prospective, multicentre, international. The study group comprises 150 primiparous or multiparous women up to 8 weeks after the vaginal (spontaneous or assisted) delivery of singleton, live foetus, in any presentation, in gestational week 34 or more. The timeline for each subject in the study will be up to 5 weeks and will include 3 visits (V1-V3). After obtaining written consent, at the first study visit (V1) each patient will undergo a general physical examination, proctological and gynaecological examination, ECG recording, 3-D EUS (endoanal ultrasound, used as a reference and for the study group allocation) and once V1 visit is conducted 3 or more days after delivery Wexner score will be used to assess the clinical symptoms of faecal incontinence. Based on the physical proctological examination and EUS at the V1 visit, all participants will be divided into 3 groups: A, B, C. Group A - subjects with no perineal tear signs, Group B - subjects with the presence of perineal skin injury or perineum injury involving crotch muscles but not involving anal sphincters (grade 1 or 2 per OASIS classification) and Group C - subjects with the presence of perineal injury involving anal sphincters (damage of the external anal sphincter thickness, damage to both the external and internal anal sphincters, or damage to the perineum, anal sphincteric complex and anal epithelium; grade 3-4). On the visit V2 performed on the same day as V1 or scheduled up to 7 days after the V1, after the final verification of inclusion/exclusion criteria, blood samples for laboratory tests and stool samples for calprotectin concentration assessment will be collected, ONIRY recording will be made, 10 minutes after the end of the impedance measurement 12-lead ECG recording will also be performed in each patient. On the third visit (V3) 1-28 days after visit V2, high-resolution Anorectal Manometry will be conducted. No control group is planned. However, study participants will be controls for themselves (test and reference diagnostic methods will be applied and evaluated in each subject). In Part I of the study, the ONIRY system will provide only preliminary interpretations of the impedance measurements based on models established from the data collected during Pilot Studies No. 1/1/2018 (NCT03769792) and No. 2/1/2019 (NCT04181840). The web-based app will be used to provide the interpretations. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04903977
Study type Interventional
Source OASIS Diagnostics S.A.
Contact
Status Completed
Phase N/A
Start date May 20, 2021
Completion date December 8, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05935371 - Consequences of Obstetric Anal Sphincter Injuries on Maternal Psychology and Relationship Experience
Completed NCT06449872 - OB-GYN Clinical Validation Study N/A
Completed NCT04181840 - Impedance Spectroscopy for Obstetric Anal Sphincter Injuries Detection N/A
Active, not recruiting NCT05354284 - Physical and Mental Health Among Sexual and Gender Minorities During Pregnancy, Birth and Postpartum
Active, not recruiting NCT04483986 - Does Rectus Re-approximation Cause Adhesion After Cesarean Section? N/A
Terminated NCT03478163 - Antibiotics During Intrauterine Balloon Tamponade Placement Phase 4
Not yet recruiting NCT06325319 - Effect of Community Engagement Using M-Mama Champions N/A
Recruiting NCT04664660 - Endometriosis and Obstetric Outcomes
Completed NCT03856307 - Reliability of Simple Sonographic Findings Acquired With Hand-held Apparatuses to Inform Obstetric Diagnosis
Recruiting NCT06273007 - Improving Intrapartum Care for Saving Life at Birth in Ethiopia Through PartoMa Approach N/A
Completed NCT03828630 - Lung Ultrasound to Detect Pulmonary Complications in Critically Ill Parturients
Completed NCT03161184 - Impact of a Smartphone Intervention on Tanzanian Women's Childbirth Location N/A
Completed NCT03653884 - Intra-abdominal Umbilical Vein Aneurysm
Completed NCT03522909 - The Center for Peripartum Optimization
Completed NCT05704179 - Evaluation of the Relationship Between Obstetric Comorbidity Index and Obstetric Quality of Recovery Score
Completed NCT05079139 - Musset's Surgical Technique: Evaluation of Long-term Results (LONGOMUSSET) N/A
Not yet recruiting NCT05307393 - Maternal Positioning to Correct Fetal Occiput Posterior N/A
Completed NCT04536753 - The Utility of Customised Growth Charts for Identifying Macrosomia and the Effect of Intervention
Completed NCT04852237 - Is the Lack of Prior Exposure to Sperm Antigens Associated With Worse Neonatal and Maternal Outcomes?
Completed NCT04894136 - Reproductive and Obstetric Outcomes in TESE-ICSI Cycles for Azoospermia